Global outbreak response and U.S. health aid oversight

Global health aid funding, cuts, and USAID authority

Decisions about keeping, cutting, pausing, redirecting, or reorganizing U.S. foreign assistance that supports global health, humanitarian response, and USAID operations.

Foreign aid transparency, audits, and congressional oversight

Reporting, notices, audits, Inspector General review, public access, performance evaluation, and foreign-aid management controls for State Department, USAID, and global health programs.

TB, HIV, vaccines, and global health systems

Disease-specific global health programs, health-worker capacity, medicines, diagnostics, vaccines, and health-system investments that can also support outbreak readiness abroad.

Aid conditions, UN funding limits, and social-policy rules

Restrictions on foreign assistance recipients, UN bodies, reproductive health policy, gender and equity rules, adversary governments, coups, terrorism, and anti-diversion safeguards.

Domestic outbreak detection and biodefense

U.S.-based systems for detecting biological threats, including DHS biodetection, wastewater surveillance, federal biotech safety planning, biological data, and research-risk limits.

Humanitarian health aid and fragile-state response

Health-related humanitarian aid, disaster response capacity, refugee and migration assistance, conflict prevention, fragile-state stabilization, and anti-diversion conditions in crisis settings.

WHO, pandemic agreements, and multilateral health rules

U.S. participation in the World Health Organization and other multilateral systems, including dues, withdrawal, Taiwan, China-related accountability, sovereignty, and Senate approval for pandemic agreements.